LEARN MORE

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.

LEARN MORE

Events

International Epilepsy Congress

9/6/17

Cantor Fitzgerald's Global Healthcare Conference

9/25/17 - 9/27/17

More Events >

Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Marinus Pharma's Twitter avatar
Marinus Pharma
@MarinusPharma

Ganaxolone is being studied in women who suffer from postpartum depression.... wanna know how it works? t.co/8ouWuWHa7u #PPD